Dr. Leavey was the Chair for the AEWS1031 study at the Children’s Oncology Group titled “Phase III Trial Adding Vincristine-Topotecan-Cyclophosphamide to the Initial Treatment of Patients With Nonmetastatic Ewing Sarcoma”.
Dr. Leavey is currently Vice-Chair for the AOST2031 (NCT05235165) study at the Children’s Oncology Group titled “Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma”.